Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis
Open Access
- 25 July 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0300408
Abstract
SARS-CoV-2, a severe respiratory disease primarily targeting the lungs, was the leading cause of death worldwide during the pandemic. Understanding the interplay between the oral microbiome and inflammatory cytokines during acute infection is crucial for elucidating host immune responses. This study aimed to explore the relationship between the oral microbiome and cytokines in COVID-19 patients, particularly those with and without sputum production. Saliva and blood samples from 50 COVID-19 patients were subjected to 16S ribosomal RNA gene sequencing for oral microbiome analysis, and 65 saliva and serum cytokines were assessed using Luminex multiplex analysis. The Mann-Whitney test was used to compare cytokine levels between individuals with and without sputum production. Logistic regression machine learning models were employed to evaluate the predictive capability of oral microbiome, salivary, and blood biomarkers for sputum production. Significant differences were observed in the membership (Jaccard dissimilarity: p = 0.016) and abundance (PhILR dissimilarity: p = 0.048; metagenomeSeq) of salivary microbial communities between patients with and without sputum production. Seven bacterial genera, including Prevotella, Streptococcus, Actinomyces, Atopobium, Filifactor, Leptotrichia, and Selenomonas, were more prevalent in patients with sputum production (pPrevotella, Megasphaera, Stomatobaculum, Selenomonas, Leptotrichia, Veillonella, Actinomyces, Atopobium, and Corynebacteria, were significantly more abundant in the sputum-producing group, while Lachnoanaerobaculum was more prevalent in the non-sputum-producing group (p<0.05, ANCOM-BC). Positive correlations were found between salivary IFN-gamma and Eotaxin2/CCL24 with sputum production, while negative correlations were noted with serum MCP3/CCL7, MIG/CXCL9, IL1 beta, and SCF (p<0.05, Mann-Whitney test). The machine learning model using only oral bacteria input outperformed the model that included all data: blood and saliva biomarkers, as well as clinical and demographic variables, in predicting sputum production in COVID-19 subjects. The performance metrics were as follows, comparing the model with only bacteria input versus the model with all input variables: precision (95% vs. 75%), recall (100% vs. 50%), F1-score (98% vs. 60%), and accuracy (82% vs. 66%).Keywords
All Related Versions
Funding Information
- J. Craig Venter Institute
- Dasman Diabetes Institute
- L'Oreal USA
This publication has 33 references indexed in Scilit:
- Oral dysbiosis and its linkage with SARS-CoV-2 infectionMicrobiological Research, 2022
- Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injuryClinical Microbiology and Infection, 2021
- Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infectionInflammation Research, 2021
- IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infectionVirus Research, 2020
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2Nature Biotechnology, 2019
- DADA2: High-resolution sample inference from Illumina amplicon dataNature Methods, 2016
- New microbiota found in sputum from patients with community-acquired pneumoniaActa Biochimica et Biophysica Sinica, 2013
- Understanding the mechanism of IL-1β secretionCytokine & Growth Factor Reviews, 2011
- Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil LeukocytesJournal of Experimental Medicine, 1997
- Monocyte chemotactic protein‐3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophilsEuropean Journal of Immunology, 1995